Log In

 

Company Name : Philip Morris International

Wednesday, February 21, 2018 5:30PM IST (12:00PM GMT)

(BW)(PHILIP-MORRIS-INTL)

Philip Morris International and Scuderia Ferrari Partner Together to Advance the Vision of a World Free of Tobacco Smoke


Lausanne, Switzerland

Philip Morris International Inc. (NYSE/Euronext Paris: PMI) and Scuderia Ferrari have extended their partnership until 2021. Their successful collaboration spans more than 40 years. As of today, the partnership will be exclusively focused on advancing the cause of a smoke-free world – a world in which all people who would otherwise continue smoking switch from the most harmful form of nicotine consumption – cigarettes – to scientifically substantiated less harmful alternatives that are smoke-free.

 

We want to give the world’s 1.1 billion men and women who smoke the opportunity to make better and informed choices. We are committed to use all available resources, including our motorsports related activities, to accelerate momentum around this revolutionary change for the benefit of people who smoke, public health and society at large. We deeply appreciate Scuderia Ferrari’s support in this cause,” said PMI’s Chief Executive Officer, André Calantzopoulos.

 

Creating global awareness of the opportunity presented by innovation, science and technology to achieve a smoke-free world is of paramount importance. In addition to PMI’s unwavering commitment to this goal, it is critical that governments, public health experts, the scientific community and civil society embrace the challenge and help put in place a sensible regulatory plan. The men and women who smoke and the people who care about them truly deserve this.

 

Scuderia Ferrari is the perfect partner for this challenge, because it harnesses a pioneering spirit, technology and innovation in a relentless pursuit of great ambitions. Our plan does not envisage any product-specific communications. We expect to announce further details in the coming months.

 

Burning tobacco generates smoke and the vast majority of harmful toxicants generally associated with smoking-related diseases. Since we became a public company in 2008, we have spent more than USD 4.5 billion to develop, substantiate and build manufacturing capacity for a wide portfolio of smoke-free products. In 2017, after only two years since commercialization started, nearly 40% of our worldwide commercial expenditure was dedicated to these innovative products. We are proud that in such a short period, according to our estimates nearly 5 million people have already stopped smoking and made the change to the most advanced of our smoke-free products. Our short term ambition is that at least one out of three of our consumers, 40 million men and women, will do the same by 2025.

 

With appropriate regulatory support, this number could be much higher by then. We hope today’s announced initiative will be an important catalyst. Find out more about our vision of a smoke-free future at www.pmi.com.

 

Philip Morris International: Who We Are

 

We are a leading international tobacco company engaged in the manufacture and sale of cigarettes and other nicotine-containing products in markets outside the United States of America. We are building our future on smoke-free products that are a much better consumer choice than continuing to smoke cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, we aim to ensure that our smoke-free products meet adult consumer preferences and rigorous regulatory requirements. Our vision is that these products ultimately replace cigarettes to the benefit of adult smokers, society, our company and our shareholders. For more information, see our PMI and PMI Science websites.

 

 

 

 


Click here for Media Contact Details
CONTACTS :

Media enquiries
Philip Morris International media office
T: +41 (0)58 242 4500
E: media@pmi.com


More News from Philip Morris International

18/06/2018 11:44PM

PMI’s Latest Clinical Results: Findings Add to Extensive Evidence Package on Risk Reduction

Likely the first ever clinical study of this magnitude to directly assess risk-reduction potential of a smoke-free product in people who switch to it. Six-month Clinical Study met primary objective: shows ...

07/06/2018 6:30PM

PMI’S Latest Scientific Update for Smoke-Free Products Highlights Independent Research

Over 20 government reports and independent, peer-reviewed studies already published on PMI’s smoke-free products. General trend of independent research is in line with PMI’s conclusions: our most ...

31/05/2018 11:28AM

Philip Morris International: Why World No Tobacco Day Should Be World No Smoking Day

Philip Morris International (PMI) will mark World No Tobacco Day with a call to recognize this day as “World No Smoking Day.” PMI is publishing informational advertisements highlighting that people who smoke ...

Similar News

22/06/2018 12:54PM

1.5 Billion Chips Sold: Technology for Passport and ID Security on the Rise

To date, Infineon Technologies AG (FSE: IFX/OTCQX: IFNNY) has sold 1.5 billion security chips with its awarded Integrity Guard technology.

No Image

22/06/2018 11:30AM Image

Unique Navigated Knee Replacement at Medica Superspecialty Hospital, A First in East

A 63-year old English school teacher from Gariahat, Mrs. Riddhima Chatterjee (name changed), was in an acute knee pain for more than 8 years. Symptoms of knee arthritis were clear. The intensity of pain increased so ...